We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.28B
AUM Growth
-$571M
(-20%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-7.02%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
985
New
54
Increased
140
Reduced
331
Closed
122
Avg Time Held
1.9
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$13.7M |
| 2 |
Coca-Cola
KO
|
+$10.7M |
| 3 |
CVS Health
CVS
|
+$9.84M |
| 4 |
Chart Industries
GTLS
|
+$4.3M |
| 5 |
Eaton
ETN
|
+$4.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.1M |
| 2 |
Apple
AAPL
|
+$17.6M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$15.8M |
| 4 |
Danaher
DHR
|
+$12.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.07% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 14.36% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Miscellaneous | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Eli Lilly
LLY
$1.12T
| $3.36M | 0.15% |
10,362
+652
| +7% | +$196K |
2014 Q1
33 quarters
|
|
102
Oracle
ORCL
$408B
| $3.31M | 0.15% |
47,439
-4,407
| -9% | -$323K |
2013 Q2
36 quarters
|
|
|
103
Meta Platforms (Facebook)
META
$1.88T
| $3.27M | 0.14% |
20,273
-57,056
| -74% | -$11M |
2016 Q3
23 quarters
|
|
104
RTX Corp
RTX
$252B
| $3.25M | 0.14% |
33,802
-115
| -0.3% | -$11.1K |
2013 Q2
36 quarters
|
|
105
Thermo Fisher Scientific
TMO
$258B
| $3.18M | 0.14% |
5,856
-22
| -0.4% | -$12.1K |
2013 Q2
36 quarters
|
|
106
Vanguard S&P 500 ETF
VOO
$1.05T
| $2.85M | 0.12% |
8,221
+966
| +13% | +$364K |
2019 Q3
11 quarters
|
|
107
Applied Materials
AMAT
$341B
| $2.82M | 0.12% |
30,950
-303
| -1% | -$33.2K |
2021 Q4
2 quarters
|
|
108
iShares S&P 500 Growth ETF
IVW
$78.2B
| $2.8M | 0.12% |
46,428
+24,994
| +117% | +$1.65M |
2015 Q4
26 quarters
|
|
109
DELISTED
Coterra Energy
CTRA
| $2.54M | 0.11% |
98,552
| – | – |
2021 Q4
2 quarters
|
|
110
Intel
INTC
$504B
| $2.49M | 0.11% |
66,431
-2,627
| -4% | -$114K |
2013 Q2
36 quarters
|
|
111
Boeing
BA
$149B
| $2.48M | 0.11% |
18,161
-50
| -0.3% | -$7.38K |
2021 Q2
4 quarters
|
|
112
Nike
NKE
$55.2B
| $2.28M | 0.1% |
22,311
-1,924
| -8% | -$228K |
2013 Q2
36 quarters
|
|
113
West Pharmaceutical
WST
$27B
| $2.26M | 0.1% |
7,466
-797
| -10% | -$259K |
2014 Q4
30 quarters
|
|
114
iShares Russell 2000 ETF
IWM
$77.5B
| $2.18M | 0.1% |
12,895
+4,937
| +62% | +$910K |
2017 Q4
18 quarters
|
|
115
IBM
IBM
$221B
| $2.15M | 0.09% |
15,221
-651
| -4% | -$87.9K |
2013 Q2
36 quarters
|
|
116
Illinois Tool Works
ITW
$77.2B
| $2.07M | 0.09% |
11,372
+151
| +1% | +$30.2K |
2013 Q2
36 quarters
|
|
117
Texas Pacific Land
TPL
$23.9B
| $2.02M | 0.09% |
12,204
| – | – |
2020 Q1
9 quarters
|
|
118
Starbucks
SBUX
$110B
| $1.95M | 0.09% |
25,479
-35,831
| -58% | -$2.75M |
2015 Q2
28 quarters
|
|
119
Philip Morris
PM
$312B
| $1.94M | 0.08% |
19,618
-18
| -0.1% | -$1.83K |
2021 Q3
3 quarters
|
|
120
Aptiv
APTV
$9.38B
| $1.92M | 0.08% |
21,553
+20,953
| +3,492% | +$2.14M |
2021 Q4
2 quarters
|
|
121
3M
MMM
$85.3B
| $1.9M | 0.08% |
17,512
-1,032
| -6% | -$125K |
2013 Q2
36 quarters
|
|
122
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $1.8M | 0.08% |
4,358
-4,383
| -50% | -$1.98M |
2013 Q2
36 quarters
|
|
123
Vanguard Dividend Appreciation ETF
VIG
$113B
| $1.8M | 0.08% |
12,541
-5,191
| -29% | -$790K |
2017 Q4
18 quarters
|
|
124
Emerson Electric
EMR
$90.4B
| $1.73M | 0.08% |
21,739
-782
| -3% | -$68.9K |
2013 Q2
36 quarters
|
|
125
Norfolk Southern
NSC
$73B
| $1.63M | 0.07% |
7,190
+334
| +5% | +$82K |
2017 Q3
19 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Cambridge Trust held 985 positions worth $2.28B, down 20% from $2.86B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cambridge Trust withdrew a net $160M in Q2 2022, closing 122 positions and reducing 331 holdings. Its most notable exit was Paycom, an estimated $915K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cambridge Trust opened a new position in Chart Industries worth $4.21M.
- Cambridge Trust's largest Q2 2022 buy was Chart Industries: 25,166 shares worth $4.21M.
- Cambridge Trust added most to ExxonMobil in Q2 2022, an estimated $13.7M increase.
- Cambridge Trust's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $45.1M.
- Cambridge Trust fully exited Paycom in Q2 2022, selling an estimated $915K.
- Cambridge Trust's ten largest holdings make up 27% of its $2.28B portfolio in Q2 2022.
- Cambridge Trust opened 54 new positions and closed 122 in Q2 2022.
- Cambridge Trust's portfolio value fell 20% quarter-over-quarter to $2.28B.
Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.